Related Experiment Videos
GATA-1 transactivates the WT1 hematopoietic specific enhancer
Y Wu1, G C Fraizer, G F Saunders
1Department of Biochemistry and Molecular Biology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
The Journal of Biological Chemistry
|March 17, 1995
Summary
The Wilms' tumor gene (WT1) is crucial for blood cell development. Research shows the GATA-1 transcription factor directly regulates WT1 expression through a specific binding site, impacting hematopoiesis.
Area of Science:
- Molecular Biology
- Hematology
- Genetics
Background:
- The Wilms' tumor gene (WT1) is implicated in hematopoiesis due to its expression patterns in fetal spleen and immature leukemia cells.
- WT1 expression is inversely correlated with cellular differentiation in leukemia, decreasing as cells mature.
Purpose of the Study:
- To investigate the transcriptional regulation of a hematopoietic-specific WT1 enhancer element.
- To identify hematopoietic-specific transcription factors that modulate WT1 enhancer activity.
Main Methods:
- Analysis of WT1 and GATA-1 mRNA co-expression in K562 cells and mouse spleen.
- Functional studies of the 3' WT1 enhancer activity in relation to GATA-1 expression.
- Gel shift competition and transactivation assays to determine transcription factor binding and activity.
Main Results:
- WT1 and GATA-1 mRNA were co-expressed in K562 cells and mouse spleen.
- The activity of the 3' WT1 enhancer showed a positive correlation with GATA-1 expression.
- Transactivation studies confirmed that GATA-1 binds to a specific GATA-binding site within the WT1 enhancer, mediating its activity.
Conclusions:
- GATA-1 directly regulates the WT1 gene during hematopoiesis.
- The findings elucidate a novel mechanism for WT1 gene regulation in blood cell development through interaction with GATA-1.